Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6175.5000 62.00 (1.01%)
NSE Feb 10, 2026 15:50 PM
Volume: 237.9K
 

logo
Divi's Laboratories Ltd.
24 Jul 2017
6175.50
1.01%
buy
by HDFC Securities
HDFC Securities
Revenue decreased by 23.01% to Rs. 821.2 Cr in Q1FY18 when compared to the previous quarter. Revenue decreased by 23.01% to Rs. 821.2 Cr in Q1FY18 when compared to the previous quarter.
 
Number of FII/FPI investors decreased from 897 to 868 in Dec 2025 qtr
More from Divi's Laboratories Ltd.
Recommended
Market closes higher on foreign fund inflows
Trendlyne Marketwatch | 10 Feb 2026, 04:00PM
IPO market gains traction with mainline offerings making a comeback
| 09 Feb 2026, 05:44PM
Custom synthesis business drives growth for Divi’s Laboratories
| 10 Mar 2022, 06:14AM